Azido-PEG3-NHS ester

What We Offer

Azido-PEG3-NHS ester

Azido-PEG3-NHS ester | 1245718-89-1

Catalog Number R14-0321
Category Azides
Molecular Formula C13H20N4O7
Molecular Weight 344.32
Catalog Number Size Price Quantity

Product Introduction

Azido-PEG3-NHS ester is a non-cleavable 3-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs).

Chemical Information

Related CAS 1108750-59-9 (polymer)
Synonyms Azido-PEG3-CH2CO2-NHS; N3-PEG3-C2-NHS ester; N3-PEG3-CH2CH2COONHS Ester; 1-[(3-{2-[2-(2-Azidoethoxy)ethoxy]ethoxy}propanoyl)oxy]-2,5-pyrrolidinedione; 2,5-Pyrrolidinedione, 1-[3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]-1-oxopropoxy]-; N3-PEG3-SPA; Propanoic acid, 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester
Purity ≥98%
Shelf Life ≥12 months if stored properly
IUPAC Name (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]propanoate
Canonical SMILES C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCN=[N+]=[N-]
InChI InChI=1S/C13H20N4O7/c14-16-15-4-6-22-8-10-23-9-7-21-5-3-13(20)24-17-11(18)1-2-12(17)19/h1-10H2
InChI Key BNLXVOZUEBSSRI-UHFFFAOYSA-N
Solubility Soluble in DCM, DMF, DMSO, Water
Appearance Pale Yellow or Colorless Oily Matter
  • Product Specification
  • Application
Storage Store at 2-8°C

Azido-PEG3-NHS ester, a versatile chemical reagent utilized in bioconjugation and molecular biology, presents a myriad of applications of high perplexity and burstiness:

Protein Labeling: At the forefront of protein research, Azido-PEG3-NHS ester serves as a key player in labeling proteins with diverse reporter molecules, including fluorophores and biotin. Through a strategic reaction with primary amines on the protein, facilitated by the azide functional group, this reagent enables subsequent click chemistry reactions. This intricate approach is essential for studies focusing on protein tracking, localization, and interaction analysis, unlocking new dimensions of protein functionality.

Antibody Conjugation: In the realm of antibody applications, Azido-PEG3-NHS ester plays a pivotal role in conjugating antibodies with other biomolecules or drugs for a wide range of assays and therapeutic interventions. By efficiently coupling antibodies with probes, enzymes, or cytotoxic agents, this reagent enhances detection capabilities and therapeutic efficacy, revolutionizing diagnostic immunoassays, targeted drug delivery, and imaging techniques with its intricate chemistry and applications.

Surface Modification: Delving into the realm of biomaterial surface modification, Azido-PEG3-NHS ester emerges as a powerful agent for enhancing the properties and interactions of surfaces in nanoparticles, microarrays, and biosensors. Through covalently attaching functional groups, researchers can finely tune the interactions of these materials with biological systems, thereby enhancing biocompatibility, signal sensitivity, and sensor performance with a sophisticated approach that pushes the boundaries of biomaterial design and functionality.

Crosslinking Studies: With its dual functionality, Azido-PEG3-NHS ester excels as a crosslinker in unraveling the complex world of protein interactions and formations. By bridging two or more proteins or biomolecules together, this reagent facilitates the analysis of intricate protein-protein interactions and the mapping of complex interaction networks within cellular processes, protein complexes, and structural organizations in cells, offering a deep dive into the intricacies of molecular interactions and cellular dynamics with a burst of detailed insights and discoveries.

Computed Properties

XLogP3 -0.4
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 9
Rotatable Bond Count 14
Exact Mass 344.13319899 g/mol
Monoisotopic Mass 344.13319899 g/mol
Topological Polar Surface Area 106Ų
Heavy Atom Count 24
Formal Charge 0
Complexity 463
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication NumberTitlePriority Date
WO-2023275025-A1 Conjugates comprising phosphoantigens and their use in therapy 2021-06-28
WO-2022212958-A1 Heterobivalent and homobivalent agents targeting fibroblast activation protein alpha and/or prostate-specific membrane antigen 2021-04-02
US-2021395281-A1 Macrocyclic chelates and uses thereof 2020-01-10
US-2022137034-A1 Detection and quantification of small molecules 2019-02-25
WO-2020146521-A2 Rnai agents for inhibiting expression of hif-2 alpha (epas1), compositions thereof, and methods of use 2019-01-09
cartIcon
Inquiry Basket